Because our data suggested a potential relationship between MSI2 expression and tumor grade in CRC metastases, we investigated the expression of E-cadherin (CDH1) (Fig 2A), in relation to MSI2, in 28 randomly chosen patients with mCRC. The gene discussed is MSI2; the disease is neoplasm.